Cover Image
市場調查報告書

Enceladus Pharmaceuticals BV的產品平台分析

Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321972
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Enceladus Pharmaceuticals BV的產品平台分析 Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015
出版日期: 2015年05月13日 內容資訊: 英文 23 Pages
簡介

Enceladus Pharmaceuticals BV是總公司設立於荷蘭的藥物研發企業,從事治療癌症,發炎,自體免疫疾病用之含皮質類固醇有微脂體製劑的開發。

本報告提供Enceladus Pharmaceuticals BV的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Enceladus Pharmaceuticals BV的基本資料

  • Enceladus Pharmaceuticals BV概要
  • 主要資訊
  • 企業資料

Enceladus Pharmaceuticals BV:R&D概要

  • 主要的治療範圍

Enceladus Pharmaceuticals BV:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Enceladus Pharmaceuticals BV:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Enceladus Pharmaceuticals BV:藥物簡介

  • Nanocort
  • dexamethasone acetate
  • Liposomal corticosteroid

Enceladus Pharmaceuticals BV:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Enceladus Pharmaceuticals BV:開發暫停中的計劃

Enceladus Pharmaceuticals BV:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07085CDB

Summary

Global Markets Direct's, 'Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015', provides an overview of the Enceladus Pharmaceuticals BV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Enceladus Pharmaceuticals BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Enceladus Pharmaceuticals BV including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Enceladus Pharmaceuticals BV's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Enceladus Pharmaceuticals BV's pipeline products

Reasons to buy

  • Evaluate Enceladus Pharmaceuticals BV's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Enceladus Pharmaceuticals BV in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Enceladus Pharmaceuticals BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Enceladus Pharmaceuticals BV and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Enceladus Pharmaceuticals BV
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Enceladus Pharmaceuticals BV and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Enceladus Pharmaceuticals BV Snapshot
    • Enceladus Pharmaceuticals BV Overview
    • Key Information
    • Key Facts
  • Enceladus Pharmaceuticals BV - Research and Development Overview
    • Key Therapeutic Areas
  • Enceladus Pharmaceuticals BV - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Enceladus Pharmaceuticals BV - Pipeline Products Glance
    • Enceladus Pharmaceuticals BV - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Enceladus Pharmaceuticals BV - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Enceladus Pharmaceuticals BV - Drug Profiles
    • prednisolone sodium phosphate liposomal
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • dexamethasone acetate liposomal
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Corticosteroid liposimal
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Enceladus Pharmaceuticals BV - Pipeline Analysis
  • Enceladus Pharmaceuticals BV - Pipeline Products by Target
  • Enceladus Pharmaceuticals BV - Pipeline Products by Route of Administration
  • Enceladus Pharmaceuticals BV - Pipeline Products by Molecule Type
  • Enceladus Pharmaceuticals BV - Pipeline Products by Mechanism of Action
  • Enceladus Pharmaceuticals BV - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Enceladus Pharmaceuticals BV, Key Information
  • Enceladus Pharmaceuticals BV, Key Facts
  • Enceladus Pharmaceuticals BV - Pipeline by Indication, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Stage of Development, 2015
  • Enceladus Pharmaceuticals BV - Monotherapy Products in Pipeline, 2015
  • Enceladus Pharmaceuticals BV - Phase II, 2015
  • Enceladus Pharmaceuticals BV - Phase I, 2015
  • Enceladus Pharmaceuticals BV - Preclinical, 2015
  • Enceladus Pharmaceuticals BV - Discovery, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Target, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Route of Administration, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Molecule Type, 2015
  • Enceladus Pharmaceuticals BV - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Indication, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Stage of Development, 2015
  • Enceladus Pharmaceuticals BV - Monotherapy Products in Pipeline, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Target, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Route of Administration, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Molecule Type, 2015
  • Enceladus Pharmaceuticals BV - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top